Already a member? Sign in
Category: Prescription Drugs
Xaliproden is a nonpeptide compound that possesses neurotrophin-like activity. Xaliproden underwent two clinical trials in ALS but was found not to be sufficiently beneficial to apply for approval.
Read more...
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Other | 1 | 0 |
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 1 | ||
| Other | 1 |
Stopped Taking Xaliproden
A bar graph
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
Report created on February 11, 2012.